Upgrade to SI Premium - Free Trial

Imperva (IMPV) Min. Price Seen at $55-$65/Share - BTIG

July 11, 2016 9:40 AM
BTIG maintained a Buy rating on Imperva (NYSE: IMPV) with a price target of $55. Analyst Joel P. Fishbein thinks ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles